Acorah Software Products - Accounts Production 15.0.500 true true false true No description of principal activity 12 September 2023 30 September 2024 30 September 2024 15132649 Mr L Li iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure 15132649 2023-09-11 15132649 2024-09-30 15132649 2023-09-12 2024-09-30 15132649 frs-core:CurrentFinancialInstruments 2024-09-30 15132649 frs-bus:PrivateLimitedCompanyLtd 2023-09-12 2024-09-30 15132649 frs-bus:FilletedAccounts 2023-09-12 2024-09-30 15132649 frs-bus:Micro-entities 2023-09-12 2024-09-30 15132649 frs-bus:EntityHasNeverTraded 2023-09-12 2024-09-30 15132649 frs-bus:AuditExempt-NoAccountantsReport 2023-09-12 2024-09-30 15132649 frs-bus:Director1 2023-09-12 2024-09-30
Registered number: 15132649
Liyan International Chinese Medical Ltd
Unaudited Financial Statements
For the Period 12 September 2023 to 30 September 2024
WD Accountants Ltd
Balance Sheet
Registered number: 15132649
30 September 2024
£
Creditors: Amounts Falling Due Within One Year (300 )
NET CURRENT LIABILITIES (300 )
TOTAL ASSETS LESS CURRENT LIABILITIES (300 )
NET LIABILITIES (300 )
CAPITAL AND RESERVES (300 )

Notes

1. General Information
Liyan International Chinese Medical Ltd is a private company, limited by shares, incorporated in England & Wales, registered number 15132649 . The registered office is 4 Fern Court, 30 Manor Road, Harrow, HA1 2PB.
2. Average Number of Employees
Average number of employees, including directors, during the period was: NIL
-
For the period ending 30 September 2024 the company was entitled to exemption from audit under section 480 of the Companies Act 2006 relating to dormant companies.
The member has not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies' regime.
On behalf of the board
Mr L Li
Director
10/10/2024